Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion description "[Our data indicate that gene polymorphism of CCR2 V64I may influence the susceptibility and clinicopathological characteristics of prostate cancer and CCR5 ?32 allele may also be an important risk factor for prostate cancer in Turkish men population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion evidence source_evidence_literature NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion SIO_000772 22612293 NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion wasDerivedFrom befree-20140225 NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion wasGeneratedBy ECO_0000203 NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- befree-20140225 importedOn "2014-02-25" NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.